Catalyst CSR Shoulder System for Semi or Total Shoulder Arthroplasty
Public ClinicalTrials.gov record NCT04968405. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Analysis of the Performance and Safety of the Catalyst CSR Shoulder System - A Prospective Study
Study identification
- NCT ID
- NCT04968405
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Catalyst OrthoScience
- Industry
- Enrollment
- 87 participants
Conditions and interventions
Conditions
Interventions
- Catalyst CSR Total Shoulder System Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 21, 2022
- Primary completion
- Jan 31, 2026
- Completion
- Jan 31, 2026
- Last update posted
- Mar 30, 2026
2022 – 2026
United States locations
- U.S. sites
- 3
- U.S. states
- 3
- U.S. cities
- 3
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Beaumont Hospital Royal Oak | Royal Oak | Michigan | 48073 | — |
| Kaiser Permanente Northwest Center for Health Research | Portland | Oregon | 97227 | — |
| Lifespan/University Orthopedics | Providence | Rhode Island | 02914 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04968405, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 30, 2026 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04968405 live on ClinicalTrials.gov.